Auto saved by Logseq

master
Borja Robert 11 months ago
parent f04a88d8a9
commit 4587f57b10

@ -38,5 +38,7 @@
- Dosing strategies for Ivermectine are being revisited
- The fix-dose coformulation of Albendazole/Ivermectine is [[due]] to enter regulatory agencies
- Acceptability and safety studies are underway
-
- The access plan is being developed
- Integration across programs (these results have implications beyond STH)
- Progress has been achieved through public-private partnerships but more partners are needed to reach the ultimate goal.
-
Loading…
Cancel
Save